Clinical Trial Update: Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated the combination of S-1 and cisplatin in advanced gastric cancer; the study is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED